Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Study On The Effect Of Thalidomide Combined With Adriamycin, Dexamethasone (AD) And High Dose Melphalan In Patients With Multiple Myeloma

NCT00028886 is registered in ClinicalTrials.gov with Commissie Voor Klinisch Toegepast Onderzoek as lead sponsor.

NCT NCT00028886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00028886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Study On The Effect Of Thalidomide Combined With Adriamycin, Dexamethasone (AD) And High Dose Melphalan In Patients With Multiple Myeloma
Lead sponsor
Commissie Voor Klinisch Toegepast Onderzoek
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2001
Completion date
Not reported
Enrollment
450 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma and plasma cell neoplasm